BRCA1 methylation status, silencing and treatment effect in the TNT trial: a randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer
dc.contributor.author | Tutt, A | |
dc.contributor.author | Cheang, M | |
dc.contributor.author | Kilburn, L | |
dc.contributor.author | Tovey, H | |
dc.contributor.author | Gillett, C | |
dc.contributor.author | Pinder, S | |
dc.contributor.author | Lanchbury, J | |
dc.contributor.author | Abraham, J | |
dc.contributor.author | Barrett, S | |
dc.contributor.author | Barrett-Lee, P | |
dc.contributor.author | Chan, S | |
dc.contributor.author | Gazinska, P | |
dc.contributor.author | Grigoriadis, A | |
dc.contributor.author | Kernaghan, S | |
dc.contributor.author | Hoadley, K | |
dc.contributor.author | Gutin, A | |
dc.contributor.author | Harper-Wynne, C | |
dc.contributor.author | Hatton, M | |
dc.contributor.author | Owen, J | |
dc.contributor.author | Parker, P | |
dc.contributor.author | Roylance, R | |
dc.contributor.author | Shaw, A | |
dc.contributor.author | Smith, I | |
dc.contributor.author | Thompson, R | |
dc.contributor.author | Timms, K | |
dc.contributor.author | Wardley, Andrew M | |
dc.contributor.author | Wilson, G | |
dc.contributor.author | Harries, M | |
dc.contributor.author | Ellis, P | |
dc.contributor.author | Ashworth, A | |
dc.contributor.author | Perou, C | |
dc.contributor.author | Bliss, J | |
dc.contributor.author | Rahman, N | |
dc.contributor.author | Brown, R | |
dc.date.accessioned | 2017-05-12T12:06:25Z | |
dc.date.available | 2017-05-12T12:06:25Z | |
dc.date.issued | 2017-02-14 | |
dc.identifier.citation | BRCA1 methylation status, silencing and treatment effect in the TNT trial: a randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer 2017, 77 (4 Supplement):S6-01 Cancer Research | en |
dc.identifier.issn | 0008-5472 | |
dc.identifier.issn | 1538-7445 | |
dc.identifier.doi | 10.1158/1538-7445.SABCS16-S6-01 | |
dc.identifier.uri | http://hdl.handle.net/10541/620342 | |
dc.language.iso | en | en |
dc.relation.url | http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.SABCS16-S6-01 | en |
dc.rights | Archived with thanks to Cancer Research | en |
dc.title | BRCA1 methylation status, silencing and treatment effect in the TNT trial: a randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Institute of Cancer Research, Breast Cancer Now, London, | en |
dc.identifier.journal | Cancer Research | en |